Skip to content

Bausch 医疗

US · BHC #2722 按市值排名 上市于 1970
6.30 -0.01 -0.16%
实时 - 追踪5344个代码 - 心跳于314秒前 · 2026-10-16 19:30

最新新闻

  • Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7
    \u5e02\u573a\u8d44\u8baf · 2026/6/4
  • 评级变动
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $6.78
    \u5e02\u573a\u8d44\u8baf · 2025/7/25
  • 评级变动
    TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7
    \u5e02\u573a\u8d44\u8baf · 2026/2/21
  • 评级变动
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8
    \u5e02\u573a\u8d44\u8baf · 2026/1/7
  • 评级变动
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/4/27
  • 公司公告
    MCOM: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BHC HOLDINGS SDN. BHD.
    Bursa Malaysia · 2026/6/5
  • 评级变动
    Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8
    \u5e02\u573a\u8d44\u8baf · 2025/8/5
  • 评级变动
    RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/2/19
  • RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9
    \u5e02\u573a\u8d44\u8baf · 2026/4/27
  • 评级变动
    Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS)
    TipRanks · 2025/10/30
  • 评级变动
    BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5
    \u5e02\u573a\u8d44\u8baf · 2026/2/19
  • 评级变动
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/2/19
  • 评级变动
    Truist Financial Initiates Bausch Health(BHC.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2025/7/30
  • 评级变动
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8
    \u5e02\u573a\u8d44\u8baf · 2026/1/24
  • RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $7 to $9
    \u5e02\u573a\u8d44\u8baf · 2026/5/1
  • 评级变动
    TR | OpenAI - 4o Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $5.81
    \u5e02\u573a\u8d44\u8baf · 2025/8/11
  • Earnings Call Summary | Bausch Health(BHC.US) Q1 2026 Earnings Conference
    \u5e02\u573a\u8d44\u8baf · 2026/4/30
  • 评级变动
    Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7
    \u5e02\u573a\u8d44\u8baf · 2026/2/25
  • 评级变动
    Analysts Offer Insights on Healthcare Companies: Heart Test Laboratories, Inc. (HSCS) and Bausch Health Companies (BHC)
    TipRanks · 2025/7/29

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Bausch 医疗 讨论区 0 条评论

发表评论